Falciparum malaria

Infectious Diseases in Critical Care

Volumn , Issue , 2007, Pages 252-262

  Feldman, C ^a   Richards, G A ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892087040     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-34406-3_24     Document Type: Chapter

References (110)

1. Greenwood BM, Bojang K, Whitty C J M, Targett G A T (2005) Malaria. Lancet 365:1487-1498
2. Murray C J L, Lopez AD (1997) Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349:1269-1276
3. Warrell DA (1997) Cerebral malaria: clinical features, pathophysiology and treatment. Ann Trop Med Parasitol 91:875-884
4. Murphy GS, Oldfield EC III (1996) Falciparum malaria. Infect Dis Clin North Am 10:747-775
5. Trampuz A, Jereb M, Muzlovic I, Prabhu RM (2003) Clinical review: Severe malaria. Critical Care 7:315-323
6. White NJ, Warrel DA (1988) The management of severe malaria. In: Wernsdorfer WH, McGregor I (eds) Principles and practice of malariology. Churchill Livingstone, Edinburgh, pp 865-888
7. World Health Organization (1990) Severe and complicated malaria. Trans R Soc Trop Med Hyg 84:1-65
8. Roberts DJ, Biggs B-A, Brown G, Newbold CI (1993) Protection, pathogenesis and phenotypic plasticity in Plasmodium falciparum malaria. Parasitol Today 9:281-286
9. Greenwood BM (1997) The epidemiology of malaria. Ann Trop Med Parasitol 91:763-769
10. Molineaux L (1996) Plasmodiumfalciparummalaria: some epidemiological implications of parasite and host diversity. Ann Trop Med Parasitol 90:379-393
11. Urquhart AD (1994) Putative pathophysiological interactions of cytokines and phagocytic cells in severe human falciparum malaria. Clin Infect Dis 19:117-131
12. Hill AV, Allsopp C E M, Kwiatkowski D, Anstey NM, Twumasi P, et al. (1991) Common West African HLA antigens are associated with protection fromseveremalaria. Nature 352:595
13. Hill AV, Elvin J, Willis AC, Aidoo M, Allsopp C E M, et al. (1992) Molecular analysis of the association of HLA B 53 and resistance to severe malaria. Nature 360:434-439
14. Allan RJ, Rowe A. Kwiatkowski D (1993) Plasmodium falciparum varies in its ability to induce tumor necrosis factor. Infect Immun 61:4772-4776
15. McGuire W, Knight JC, Hill A V S, Allsopp C E M, Greenwood BM, et al. (1999) Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 179:287-290
16. McGuire W, Hill A V S, Allsopp C E M, Greenwood BM, Kwiatkowski D (1994) Variation in the TNF-[promoter region associated with susceptibility to cerebral malaria. Nature 371:508-510
17. Idro R, Jenkins NE, Newton C R JC (2005) Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol: 827-840
18. WHO (2000) Severe falciparum malaria. Trans R Soc Trop Med Hyg 94(Suppl 1):1-90
19. Clark IA, Alleva LM, Mills AC, Cowden WB (2004) Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev 17:509-539
20. Mackintosh CL, Beeson JG, Marsh K (2004) Clinical features and pathogenesis of severe malaria. Trends Parasitol 20:597-603
21. Bruneel F, Hocqueloux L, Alberti C, Wolff M, Chevret S, Bedos J-P, Durand R, Le Bras J, Regnier B, Vachon F (2003) The clinical spectrum of severe imported falciparum malaria in the intensive care unit. Report of 188 cases in adults. Am J Respir Crit Care Med 167:684-689
22. Dondorp AM, Chau T T H, Phu NH, Mai N T H, Loc PP, Chuong LV, Sinh DX, Taylor A, Hien TT, White NJ, Day N P J (2004) Unidentified acids of strong prognostic significance in severe malaria. Crit Care Med 32:1683-1688
23. Chiwakata CB, Manegold C, Bonicke L, Waase I, Julch C, Dietrich M (2001) Procalcitonin as a parameter of disease severity and risk ofmortality in patients with Plasmodium falciparum malaria. J Infect Dis 183:1161-1164
24. Chirenda J, Siziya S, Tshimanga M (2000) Association of HIV infection with the development of severe and complicated malaria cases at a rural hospital in Zimbabwe. Cent Afr J Med 46:5-9
25. Lawn SD (2004) AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. J Infect 48:1-12
26. White NJ (2004) Antimalarial drug resistance. J Clin Invest 113:1084-1092
27. Pasloske BL, Howard RJ (1994) Malaria, the red cell, and the endothelium. Annu Rev Med 45:283-295
28. Berendt AR, Turner G D H, Newbold CI (1994) Cerebral malaria: the sequestration hypothesis. Parasitol Today 10:412-414
29. MacPherson GG, Warrell MJ, White NJ, Looareesuwan S, Warrell DA (1985) Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol 119:385-401
30. Dondorp AM, Pongponratn E, White NJ (2004) Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology. Acta Tropica 89:309-317
31. Kirchgatter K, Del Portillo HA (2005) Clinical and molecular aspects of severe malaria. An Acad Bras Cienc 77:455-475
32. Armah H, Dodoo AK, Wiredu EK, Stiles JK, Adjei AA, Gyasi RK, Tettey Y (2005) High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria. Ann Trop Med Parasitol 99:629-647
33. Miller LH, Good MF, Milon G (1994) Malaria pathogenesis. Science 264:1878-1883
34. Phillips RE, Warrell DA (1986) The pathophysiology of severe falciparum malaria. Parasitol Today 2:271-282
35. Warrell DA, Looareeuwan S, Phillips RE, White NJ, Warrel MJ, et al. (1986) Function of the blood-cerebrospinal fluid barrier in human cerebralmalaria: rejection of the permeability hypothesis. Am J Trop Med Hyg 35:882-889
36. Usawattanakul W, Tharavanij S, Warrell DA, Looareesuwan W, White NJ, et al. (1985) Factors contributing to the development of cerebral malaria II. Endotoxin. Clin Exp Immunol 61:562-568
37. Grau GE, de Kossodo S (1994) Cerebral malaria: mediators, mechanical obstruction or more? Parasitol Today 10:408-409
38. Clark IA, Chaudhri G, Cowden WB (1989) Roles of tumour necrosis factor in the illness and pathology of malaria. Trans R Soc Trop Med Hyg 83:436-440
39. Clark IA, Rockett KA, Cowden WB (1991) Proposed link between cytokines, nitric oxide and human cerebral malaria. Parasitol Today 7:205-207
40. Clark IA, Rockett KA (1994) The cytokine theory of human cerebral malaria. Parasitol Today 10:410-412
41. Coltel N, Combes V, Hunt NH, Grau GE (2004) Cerebral malaria-a neurovascular pathology with many riddles still to be solved. Curr Neurovasc Res 1:91-110
42. Vespa P (1998) Neurological complications of critical medical illnesses and transplantation. Curr Opin Crit Care 4:69
43. Bain BJ, Chiodini PL, England JM, Bailey JW (1997) The laboratory diagnosis of malaria. Clin Lab Haem 19:165-170
44. Perandin F, Manca N, Calderaro A, Piccolo G, Galati L, Ricci L, Medici MC, Arcangeletti MC, Snounou G, Dettori G, Chezzi C (2004) Development of a real-time PCR assay for detection of Plasmodium falciparum, Plasmodium vivax, and Plasmodiumovale for routine clinical diagnosis. J Clin Microbiol 42:1214-1219
45. Farcas GA, Zhong KJ, Lovegrove FE, Graham CM, Kain KC (2003) Evaluation of the Binax NOWICT test versus polymerase chain reaction and microscopy for the detection of malaria in returned travelers. Am J Trop Med Hyg 69:589-592
46. Durand F, Crassous B, Fricker-Hidalgo H, Carpentier F, Brion JP, Grillot R, Pelloux H (2005) Performance of the NowMalaria rapid diagnostic testwith returned travellers: a 2-year retrospective study in a French teaching hospital. Clin Microbiol Infect 11:903-907
47. Pamba A, Maitland K (2004) Fluid management of severe falciparum malaria in African children. Tropical Doctor 34:67-70
48. Maitland K, Pamba A, English M, Peshu N, Levin M Marsh K, Newton C R JC (2005) Pre-transfusion management of children with severe malarial anaemia: a randomized controlled trial of intravascular volume expansion. Br J Haematol 128:393-400
49. Riddle MS, Jackson JL, Sanders JW, Blazes DL (2002) Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: A meta-analysis. Clin Infect Dis 34:1192-1198
50. Molyneux M, Fox R (1993) Diagnosis and treatment of malaria in Britain. Br Med J 306:1175-1180
51. White NJ (1996) Current concepts: the treatment ofmalaria. N Engl J Med 335:800-806
52. Lesi A, Meremikwu M (2004) High first dose quinine regimen for treating severe malaria. The Cochrane database of systematic reviews, Issue 3. John Wiley, Chichester, UK
53. White NJ, Nosten F, Looareeuwan S, Watkins WM, Marsh K, et al. (1999) Averting a malaria disaster. Lancet 353:1965-1967
54. Hoffman SL (1996) Artemether in severemalaria-still too many deaths. N Engl J Med 335:124-126
55. Tran TH, Day NP, Nguyen HP, Nguyen TH, Tran TH, Pham PL, Dinh XS, Ly VC, Ha V, Waller D, Peto TE, White NJ (1996) A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 335:76-83
56. Mohanty S, Mishara SK, Satpathy SK, Dash S, Patnaik J (1997) [, q-Arteether for the treatment of complicated falciparum malaria. Trans R Soc Trop Med Hyg 91:328-330
57. van Hensbroek MB, Onyiorah E, Jaffar S, Schneider G, Palmer A, et al. (1996) A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 335:69-75
58. van Vugt M, Brockman A, Gemperli B, Luxemburger C, Gathmann I, et al. (1998) Randomized comparison of artemetherbenflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antimicrob Agents Chemother 42:135-139
59. Awad MI, Alkadru A M Y, Behrens RH, Baraka OZ, Eltayeb IB (2003) Descriptive study on the efficacy and safety of artesunate suppository in combination with other antimalarials in the treatment of severe malaria in Sudan. Am J Trop Med Hyg 68:153-158
60. Aceng JR, Byarugaba JS, Tumwine JK (2005) Rectal artemether versus intravenous quinine for the treatment of cerebralmalaria in children in Uganda: randomized clinical trial. BMJ 330:334-338
61. Ashley EA, White NJ (2005) Artemisinin-based combinations. Curr Opin Infect Dis 18:531-536
62. Whitty C J M, Ansah E, Reyburn H (2005) Treating severe malaria. BMJ 330:317-318
63. South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) Group (2005) Artesunate versus quinine for treatment of severe falciparum malaria: a randomized trial. Lancet 366:717-725
64. McIntosh HM, Olliaro P (2000) Artemisinin derivatives for treating severemalaria. The Cochrane database of systematic reviews, Issue 2. John Wiley, Chichester, UK
65. Huda SN, Shahab T, Ali SM, Afzal K, Khan HM (2003) A comparative clinical trial of artemether and quinine in children with severe malaria. Indian Pediatr 40:939-945
66. Adam I, Idris HM, Mohamed-Ali AA, Aelbasit IA, Elbashir MI (2002) Comparison of intramuscular artemether and intravenous quinine in the treatment of Sudanese children with severe falciparum malaria. East Afr Med J 79:621-625
67. Haynes RK, Krishna S (2004) Artemisinins: activities and actions. Microbes Infection 6:1339-1346
68. Newton PN, Angus BJ, Chierakul W, Dondorp A, Ruangveerayuth R, Silamut K, Teerapong P, Suputtamongkol Y, Looareesuwan S, White NJ (2003) Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria. Clin Infect Dis 37:7-16
69. Krudsood S, Wilairatana P, Vannaphan S, Treeprasertsuk S, Silachamroon U, Phomrattanaprapin W, Gourdeuk VR, Brittenham GM, Looareesuwan S (2003) Clinical experience with intravenous quinine, intramuscular artemeter and intravenous artesunate for the treatment of severe malaria in Thailand. Southeast Asian J Trop Med Public Health 34:54-61
70. Mohanty AK, Rath BK, Mohanty R, Samal AK, Mishra K (2004) Randomized control trial of quinine and artesunate in complicated malaria. Indian J Pediatr 71:291-295
71. Woodrow CJ, Haynes RK, Krishna S (2005) Artemisinins. Postgrad Med J 81:71-78
72. Menard D, Matsika-Claquin MD, Djalle D, Yapou F, Manirakiza A, Dolmazon V, Sarda J, Talarmin A (2005) Association of failures of seven-day courses of artesunate in a nonimmune population in Bangui, central African Republic with decreased sensitivity of Plasmodium falciparum. Am J Trop Med Hyg 73:616-621
73. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalan O (2005) Resistance of Plasmodium falciparum field isolates to in-vitro artemether and pointmutations of the SERCA-type PfATPase. Lancet 366:1960-1963
74. Duffy PE, Sibley CH (2005) Are we losing artemisinin combination therapy already? Lancet 366:1908-1909
75. Maitland K, Makanga M, Williams TN (2004) Falciparum malaria: current therapeutic challenges. Curr Opin Infect Dis 17:405-412
76. Warrell DA, Looareesuwan S, Warrell M, Kasemsarn P, Intaraprasert R, et al. (1982) Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med 306:313-319
77. Hoffman SL, Rustama D, Punjabi NH, Surampaet B, Sanjaya B, et al. (1988) High dose dexamethasone in quininetreated patients with cerebral malaria: A double-blind, placebo-controlled trial. J Infect Dis 158:325-331
78. Looareesuwan S, Warrell DA, White NJ, Sutharasamai P, Chanthavanich, et al. (1983) Do patients with cerebral malaria have cerebral oedema? A computed tomography study. Lancet i: 434-437
79. Wilairatana P, Looareesuwan S (1995) APACHE II scoring for predicting outcome in cerebral malaria. J Trop Med Hyg 98:256-260
80. Marik P, Varon J (2004) The management of status epilepticus. Chest 126:582-591
81. Trang T T M, Phu NH, Vinh H, Hien TT, Cuong BM, et al. (1992) Acute renal failure in patients with severe falciparum malaria. Clin Infect Dis 15:874-880
82. Wilairatana P, Westerlund EK, Ausudkij B, Vannaphan S, Krudsood S, et al. (1999) Treatment of malarial acute renal failure by hemodialysis. Am J Trop Med Hyg 60:233-237
83. Bunchman TE (2004) Fluid overload in multiple organ dysfunction syndrome: prediction of survival. Crit Care Med 32:1805-1806
84. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G (2000) Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet 356:26-30
85. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, Singer M (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360:219-223
86. Panosian CB (1998) Editorial response: Exchange blood transfusion in severe falciparum malaria-the debate goes on. Clin Infect Dis 26:853-854
87. White NJ, Warrell DA, Chanthavanigh P, Looareesuwan S, Warrell MJ, et al. (1983) Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl JMed 309:61-66
88. Bruneel F, Gachot B, Timsit JF, Wolff M, Bedos JP, et al. (1997) Shock complicating severe falciparum malaria in European adults. Intensive Care Med 23:698-701
89. Beeson JG, Duffy PE (2005) The immunology and pathogenesis of malaria during pregnancy. Curr TopMicrobiol Immunol 297:187-227
90. Adam I, Mirghani OA, Saed OK, Ahmed SM, Mohamadani AA, Ahmed HM, Mackenzie CD, Homeida MM, Elbashir MI (2004) Quinine therapy in severe Plasmodium falciparum malaria during pregnancy in Sudan. East Mediterr Health J 10:159-166
91. Newton C R JC, Taylor TE, Whitten RO (1998) Pathophysiology of fatal falciparummalaria in African children. Am J Trop Med Hyg 58:673-683
92. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, et al. (1995) Indicators of life-threatening malaria in African children. N Engl J Med 332:1399-1404
93. Marsh K, English M, Crawley J (1996) The pathogenesis of severe malaria in African children. Ann Trop Med Parasitol 90:395-402
94. O'Dempsey TJ, McArdle TF, Laurence BE, Lamont AC, Todd JE, et al. (1993) Overlap in the clinical features of pneumonia and malaria in African children. Trans R Soc Trop Med Hyg 87:662-665
95. Allen SJ, O'Donnell A, Alexander N D E, Clegg JB (1996) Severemalaria in children in PapuaNewGuinea. QJ Med 89:779-788
96. Brewster DR, Kwiatkowski D, White NJ (1990) Neurological sequelae of cerebral malaria in children. Lancet 336:1039-1043
97. Greenwood BM (1997) What's new in malaria control? Ann Trop Med Parasitol 91:523-531
98. WHO Malaria Unit (1993) Global malaria control. Bull World Health Organ 71:281-284
99. Tripathi RP, Mishra RC, Dwivedi N, Tewari N, Verma SS (2005) Current status of malaria control. CurrMed Chem 12:2643-2659
100. Brown GV (1993) Chemoprophylaxis of malaria. Med J Aust 159:187-196
101. Playfair J H L, Taverne J, Bate C A W, de Souza JB (1990) The malaria vaccine: anti-parasite or anti-disease? Immunol Today 11:25-27
102. Clark IA, Rockett KA (1994) Immunizing against toxic malarial antigens. Parasitol Today 10:6
103. Amador R, Patarroyo M (1996) Malaria vaccines. J Clin Immunol 16:183-189
104. Kwiatkowski D, Marsh K (1997) Development of a malaria vaccine. Lancet 350:1696-1701
105. Urdaneta M, Prata A, Stuchiner CJ, Tosta CE, Tauil P, et al. (1998) Evaluation of SPf66 malaria vaccine efficacy in Brazil. Am J Trop Med Hyg 58:378-385
106. Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, et al. for the RTS, S Malaria Vaccine Evaluation Group (1997) A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodiumfalciparum malaria. N Engl J Med 336:86-91
107. Greenwood B (2005) Malaria vaccines evaluation and implementation. Acta Tropica 95:298-304
108. Shibui A, Shiibashi T, Nogami S, Sugano S, Watanabe J (2005) A novel method for development of malaria vaccines using full-length cDNA libraries. Vaccine 23:4359-4366
109. Moorthy VS, Good MF, Hill A V S (2004) Malaria vaccine developments. Lancet 363:150-156
110. Graves P, Gelband H (2003) Vaccines for preventing malaria. The Cochrane database of systematic reviews, Issue 1. John Wiley, Chichester, UK